Immunoregulation of Murine Plasmacytoma I. Generation of Anomalous Killer Cells in Vitro by Cocultivation with MOPC 104E

References

• North R J. The murine antitumor immune response and its therapeutic manipulation. Adv Immunol 1984; 35: 89–153
   PubMed Web of Science ®Google Scholar
• Mills C D, North R J. Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells. J Exp Med 1983; 157: 1448–1460
   PubMed Web of Science ®Google Scholar
• Loveland B E, Hogarth P M, Ceredig R, McKenzie I FC. Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med 1981; 153: 1044–1057
   PubMed Web of Science ®Google Scholar
• LeFrancois L, Bevan M J. A reexamination of the role of Lyt-2-positive T cells in murine skin graft rejection. J Exp Med 1984; 159: 57–67
   PubMed Web of Science ®Google Scholar
• Greenberg P D, Cheever M A, Fefer A. Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2-lymphocytes. J Exp Med 1981; 154: 952–963
   PubMed Web of Science ®Google Scholar
• Greenberg P D, Kern D E, Cheever M A. Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+ 2- T cells. Tumor eradication does not require participation of cytotoxic T cells. J Exp Med 1985; 161: 1122–1134
   PubMed Web of Science ®Google Scholar
• Jondal M, Targan S. In vitro induction of cytotoxic effector cells with spontaneous killer cell specificity. J Exp Med 1977; 148: 1621–1636
   Google Scholar
• Seeley J K, Golub S H. Studies on cytotoxicity generated in human mixed lymphocyte cultures. I. Time course and target spectrum of several distinct concomitant cytotoxic activities. J Immunol 1978; 120: 1415–1422
   PubMed Web of Science ®Google Scholar
• Karre K, Seeley J K. Cytotoxic Thy 1.2-positive blasts with NK-like target selectivity in murine mixed lymphocyte cultures. J Immunol 1979; 123: 1511–1518
   PubMed Web of Science ®Google Scholar
• Karre K, Seeley J K, Eriksson E, et al. Anomalous thy-1+ killer cells in allogeneic and F1-anti-parental mixed leukocyte culture. Relation to natural killer cells and allospecific cytotoxic T lymphocytes. J Exp Med 1983; 156: 385–401
   Google Scholar
• Phillips J H, Le A M, Lanier L L. Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens. J Exp Med 1984; 159: 993–1008
   PubMed Web of Science ®Google Scholar
• London L, Perussia B, Trinchiere G. Induction of proliferation in vitro of resting human natural killer cells: Expression of surface activation antigens. J Immunol 1985; 134: 718–727
   PubMed Web of Science ®Google Scholar
• Grimm E A, Mazumder A, Zhang H Z, Rosenberg S A. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2- activated autologous human peripheral blood lymphocytes. J Exp Med 1982; 155: 1823–1841
   PubMed Web of Science ®Google Scholar
• Grimm E A, Ramsey K M, Mazumder A, et al. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells. J Exp Med 1983; 157: 884–897
   PubMed Web of Science ®Google Scholar
• Merluzzi V J, Savage D M, Mertelsmann R, Welte K. Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2. Cell Immunol 1984; 84: 74–84
   PubMed Web of Science ®Google Scholar
• Williams R M, Germain R N, Benacerraf B. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells. J Natl Cancer Inst 1975; 54: 697–708
   PubMed Web of Science ®Google Scholar
• Flood P M, Phillips C, Taupier M A, Schreiber H. Regulation of myeloma growth in vitro by idiotype-specific T lymphocytes. J Immunol 1980; 124: 424–430
   PubMed Web of Science ®Google Scholar
• Burton R, Thompson J, Warner N L. In vitro induction of tumor-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes. J Immunol Methods 1975; 8: 133–150
   PubMed Web of Science ®Google Scholar
• Ghanta V K, Hiramoto R N, Davis D W, Hiramoto N S. Maintenance of MOPC 104E myeloma in plateau phase. Cancer Res 1980; 40: 2372–2376
   PubMed Web of Science ®Google Scholar
• Namba Y, Hanaoka M. Immunocytology of cultured IgM-forming cells of mouse. I. Requirement of phagocytic cell factor for the growth of IgM-forming tumor cells in tissue culture. J Immunol 1972; 109: 1193–1200
   PubMed Web of Science ®Google Scholar
• Shrestha K, Hiramoto R N, Ghanta V K. Regulation of MOPC 104E by T cells and growth factors induced by C. parvum stimulation. Int J Cancer 1984; 33: 845–850
   PubMed Web of Science ®Google Scholar
• Wang K C, Berczi I, Sehon A H. Effector and enhancing lymphoid cells in plasmacytoma-bearing mice. I. Methodological studies on the Winn assay. Int J Cancer 1980; 25: 487–492
   PubMed Web of Science ®Google Scholar
• Wang K C, Berczi I, Hoffman E G, Sehon A H. Effector and enhancing lymphoid cells in plasmacytoma-bearing mice. II. Dynamic changes during tumor progression. Int J Cancer 1980; 25: 493–501
   PubMed Web of Science ®Google Scholar
• Burton R C, Chism S E, Warner N L. In vitro induction of tumor specific immunity. VII.Does autosensitization occur with in vitro culture of T lymphocytes. J Immunol 1977; 119: 1329–1339
   PubMed Web of Science ®Google Scholar
• Igarashi T, Okada M, Kishimoto T, Yamamura Y. In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process. J Immunol 1977; 118: 1697–1703
   PubMed Web of Science ®Google Scholar
• Russel S W, McIntosh A T. Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas. Nature 1977; 268: 69–71
   PubMed Web of Science ®Google Scholar
• Welsh R M. Cytotoxic cells induced during lymphocytic choriomeningitis virus infection of mice. I. Characterization of natural killer cell induction. J Exp Med 1978; 148: 163–181
   PubMed Web of Science ®Google Scholar
• Habu S, Fukui H, Shimamura K, et al. In vivo effects of anti-asialo GMI.I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol 1981; 127: 34–38
   PubMed Web of Science ®Google Scholar
• Mule J J, Shu S, Schwarz S L, Rosenberg S A. Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2. Science 1984; 225: 1487–1489
   PubMed Web of Science ®Google Scholar
• Mule J J, Yang J, Shu S, Rosenberg S A. The antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: Direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells. J Immunol 1986; 136: 3899–3909
   PubMed Web of Science ®Google Scholar